MaxCyte Inc at Morgan Stanley Global Healthcare Conference Transcript
Good afternoon, everybody. My name is Valerie Dixon. I'm the Managing Director that covers the life sciences tools and diagnostics space at Morgan Stanley's Healthcare Investment Banking division. We're very excited to host Doug Doerfler from MaxCyte.
And before I get started, I have to do the obligatory research disclaimer. So bear with me. For important disclosures, please view the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep. And with that out of the way, we can get started.
So first, Doug, would love to give you the opportunity to just spend a few minutes for those who are not familiar with the story to give us a bit of an introduction.
Sure. Well, thanks, Valerie, and thanks for having MaxCyte at your conference. Really appreciate it. So the MaxCyte is really focused on enabling the engineering of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
